Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: A disease or a drug effect?

Keyphrases

• Chronic Myeloid Leukemia 100%
• Drug Effects 100%
• Marrow 100%
• Imatinib Mesylate 100%
• Gelatinous Bone Marrow Transformation 100%
• Hematological Malignancies 33%
• Possible Mechanisms 33%
• Pathological Manifestations 33%
• Published Data 33%
• Tyrosine Kinase Inhibitor 33%
• Therapeutic Potential 33%
• Malignant Disease 33%
• Treatment Course 33%
• Severe Malnutrition 33%
• Chronic Phase 33%

Medicine and Dentistry

• Imatinib 100%
• Chronic Myelogenous Leukemia 100%
• Drug Effect 100%
• Diseases 100%
• Hematologic Malignancy 33%
• Tyrosine-Kinase Inhibitor 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Imatinib 100%
• Chronic Myeloid Leukemia 100%
• Diseases 100%
• Hematologic Malignancy 33%
• Protein Tyrosine Kinase Inhibitor 33%